Evaluation of the activity of cefepime/enmetazobactam against Enterobacterales bacteria collected in Europe from 2019 to 2021, including third-generation cephalosporin-resistant isolates.

Ian MorrisseyStephen HawserNimmi KothariNathalie DunkelJuan QuevedoAdam BelleyAnne Santerre HenriksenMarie Attwood

Published in: Journal of global antimicrobial resistance (2024)

Cefepime/enmetazobactam was highly active against Enterobacterales isolates, especially those resistant to third-generation cephalosporins. These data suggest that cefepime/enmetazobactam could be used as a carbapenem-sparing agent to replace piperacillin/tazobactam.

Keyphrases

gram negative
multidrug resistant
klebsiella pneumoniae
electronic health record
escherichia coli
drug resistant
data analysis
artificial intelligence